Dr. Reddy’s trades higher on the bourses

11 Sep 2015 Evaluate

Dr. Reddys Laboratories is currently trading at Rs. 3981.30, up by 8.05 points or 0.20% from its previous closing of Rs. 3973.25 on the BSE.

The scrip opened at Rs. 4017.00 and has touched a high and low of Rs. 4025.00 and Rs. 3969.00 respectively. So far 5917 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 4337.00 on 14-Aug-2015 and a 52 week low of Rs. 2883.40 on 17-Oct-2014.

Last one week high and low of the scrip stood at Rs. 4205.00 and Rs. 3856.00 respectively. The current market cap of the company is Rs. 67945.41 crore.

The promoters holding in the company stood at 25.48% while Institutions and Non-Institutions held 43.67% and 13.81% respectively.

Dr. Reddy’s Laboratories, a leading global pharmaceutical company, has entered into a multi-country supply and licensing agreement with PanTheryx, Inc., a global medical nutrition company based in Boulder, Colorado. The agreement grants Dr. Reddy’s the exclusive right to market and distribute PanTheryx’s breakthrough nutritional intervention, DiaResQ, for infectious diarrhea in India and Nepal and in process for Russia, Myanmar, Vietnam, Ukraine, Sri Lanka, Kazakhstan, Belarus, Jamaica, and select LATAM markets. The pharma major will market the product in India and Nepal under the ‘Reliqua’ brand.

DiaResQ helps promote intestinal repair and boost natural immune defenses, resulting in the restoration of normal digestive function. The product was recently recognized in Reimagining Global Health as one of the 30 leading healthcare innovations with great promise to transform global health by 2030.

Dr. Reddy’s is an integrated global pharmaceutical company, committed to providing affordable and innovative medicines for healthier lives. Through its three businesses - Pharmaceutical Services and Active Ingredients, Global Generics and Proprietary Products - the company offers a portfolio of products and services including APIs, custom pharmaceutical services, generics, bio-similars, differentiated formulations and NCEs.

Dr. Reddys Lab Share Price

1208.45 -15.85 (-1.29%)
29-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1589.30
Dr. Reddys Lab 1208.45
Cipla 1320.35
Zydus Lifesciences 890.20
Lupin 2131.80
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×